Boehringer Ingelheim has landed an exclusive license to Prime Vector Technologies’ (PVT) viral vector platform for developing ...
A newly found chain-reaction phase change in 2D MoTe2 lowers energy barriers, enabling faster control of electronic and ...
Fresh with a rebrand, Cyllene will advance gene therapies built on a platform that uses a modified form of the herpes virus for delivery.
zDivision of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy aaDepartment of Precision and Regenerative Medicine and Ionian Area, Aldo Moro ...
lCritical Illness, Brain Dysfunction, and Survivorship Center (CIBS), Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine at Vanderbilt University Medical Center, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results